L., Dos Santos, T
The 21st century has seen significant progress in GLP-1R agonist research, with liraglutide (exenatide) becoming the first GLP-1R agonist to be approved by the US Food and Drug Administration (FDA) for the treatment of T2DM in 2005 (Jensterle et al., 2022)
Animals were treated daily for 1 week, and change in tumour volume was normalized to day 0
: Sahebnasagh A, Avan R, Monajati M, Hashemi J, Habtemariam S, Negintaji S, Saghafi F
Additionally, blockade of GLP-1Rs in the LS with exendin-9 alone enhanced sucrose and oil intake indicating a physiologic role for these neurons to suppress food intake
Gastrointestinal Side Effects and Menstrual Discomfort Mounjaro can cause: Nausea Constipation Diarrhoea Abdominal discomfort These may overlap with PMS symptoms, making it harder to distinguish between side effects and menstrual pain